DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Möricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, Dördelmann M. et al.
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: Treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
Blood 2008;
111: 4477-89
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.